Trump confirms U.S. Bitcoin reserve, no more sales of seized BTC
President Donald Trump has signed an executive order to establish a Strategic Bitcoin Reserve
3 Reasons to Avoid ROK and 1 Stock to Buy Instead
Rockwell Automation trades at $274.49 and has moved in lockstep with the market. Its shares have returned 5.9% over the last six months while the S&P 500 has gained 5.2%.
3 Reasons to Avoid KLIC and 1 Stock to Buy Instead
Kulicke and Soffa currently trades at $37.36 per share and has shown little upside over the past six months, posting a small loss of 3.5%. The stock also fell short of the S&P 500’s 5.2% gain during that period.
3 Reasons to Sell CAKE and 1 Stock to Buy Instead
Over the past six months, The Cheesecake Factory has been a great trade, beating the S&P 500 by 28.4%. Its stock price has climbed to $48.75, representing a healthy 33.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell BKD and 1 Stock to Buy Instead
Over the last six months, Brookdale’s shares have sunk to $5.81, producing a disappointing 15.9% loss - a stark contrast to the S&P 500’s 5.2% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons MD is Risky and 1 Stock to Buy Instead
Pediatrix Medical Group has been on fire lately. In the past six months alone, the company’s stock price has rocketed 51.5%, reaching $16 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.
3 Reasons CHTR is Risky and 1 Stock to Buy Instead
Charter’s 17.9% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $383.08 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell EVH and 1 Stock to Buy Instead
Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Solana Co-Founder Opposes U.S. Crypto Reserve, Warns It Could Undermine Decentralization
Solana co-founder Anatoly Yakovenko has voiced his opposition to the creation of a U.S. crypto reserve, warning that it could compromise decentralization.
Popular Post
- eToro to restrict U.S. crypto trading after SEC settlement, pay $1.5 million fine Sep 12, 2024
- January jobs report: Unemployment rate falls to 4%, wages rise more than forecast as US labor market remains resilient to start 2025 Feb 07, 2025
- Elizabeth Warren to Face Pro-Crypto Lawyer John Deaton in Senate Race Sep 03, 2024